LB
64
18
EMC
36
9
FSLR
47
-2
FOX
75
5
JPM
57
5
EQT
33
-4
STI
46
-4
SCHW
45
2
DG
29
12
GOOG
67
2
EBAY
40
-2
FFIV
60
2
NRG
39
12
C
51
5
A
48
4
MO
51
3
PAYX
38
2
ZION
59
4
PWR
60
4
NEE
46
4
LB
64
18
EMC
36
9
FSLR
47
-2
FOX
75
5
JPM
57
5
EQT
33
-4
STI
46
-4
SCHW
45
2
DG
29
12
GOOG
67
2
EBAY
40
-2
FFIV
60
2
NRG
39
12
C
51
5
A
48
4
MO
51
3
PAYX
38
2
ZION
59
4
PWR
60
4
NEE
46
4
Financhill
Back

Altimmune Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31

ALT
Altimmune

Last Price:
$7.28
Seasonality Move:
-4.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Today's Fastest Growing Company Might Surprise You

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 19.3% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $7.26. The Score for ALT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 19.3% based on the past 19 years of stock performance.

Altimmune Stock Rating

Sell
31
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%

Altimmune Stock Price History

Is ALT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
5.28

Prediction Charts

Market Cap:
516.4M
Price in USD:
7.26
Volume:
2.7M
Beta:
1.18

Technical Analysis

SMA50:
8.00
SMA100:
7.36
SMA200:
7.34
52-Wk Change:
-26.89%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 7.26 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 8.64 9.03 9.17 8.46
Dec-16 9.06 9.00 9.59 8.95
Dec-17 8.85 8.40 8.88 8.32
Dec-18 8.38 7.91 8.58 7.70
Dec-19 8.10 8.18 8.47 7.87
Dec-20 8.31 8.27 8.75 8.18
Dec-23 8.22 7.76 8.25 7.69
Dec-24 7.76 7.55 7.80 7.50
Dec-26 7.47 8.00 8.05 7.37
Dec-27 7.90 7.67 8.03 7.48
Dec-30 7.46 7.32 7.61 7.17
Dec-31 7.40 7.21 7.53 7.05
Jan-2 7.31 7.11 7.41 6.95
Jan-3 7.18 7.26 7.38 7.13

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.54 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.